Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Abdelaziz A. Saleh, MD, Ph.D, FACOG, practices maternal fetal medicine in the Department of Obstetrics and Gynecology at Fairview Hospital, which is part of the Cleveland Clinic healthcare network.
Dr. Saleh is board certified in obstetrics and gynecology, and maternal fetal medicine. He earned his medical degree and a master’s of science degree in obstetrics and gynecology from Ain Schams University in Cairo, Egypt. He also completed a doctoral degree focusing on bleeding disorders in pregnancy at Wane State University in Detroit, Michigan. His post-graduate training includes an obstetrics and gynecology residency at Ain Schams University Hospitals in Cairo, Egypt, an obstetrics and gynecology residency at North Oakland Medical Center and Pontiac General Hospital in Pontiac Michigan; and a maternal-fetal medicine fellowship at Wayne State University and Hutzel Hospital in Detroit, Michigan.
Dr. Saleh has directed a number of research projects and has published multiple studies in peer-reviewed journals, as well as having contributed abstracts and presentations at a number of professional association meetings. He also has been an invited speaker for local and national media outlets.
Dr. Saleh is an expert in treating disseminated intravascular coagulopathy (DIC) and blood coagulation disorders in pregnancy in obstetrics. Additional specialty interests include pregnancy after IVF and infertility procedures, obstetric ultrasound, prenatal diagnosis and invasive fetal testing, fetal therapy and intrauterine fetal blood transfusion, preconception counseling, and hypertensive disorders in pregnancy.
Obstetric ultrasound, prenatal diagnosis, fetal therapy, critical care in obstetrics, medical complications with pregnancy, genetics
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Saleh's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.